Dynavax Technologies Corporation Share Price

NASDAQ: DVAX

Small Cap

$9.62

-0.07

(-0.77%)

Live

as on September 17, 2025 at 9:42 pm IST

$₹

Dynavax Technologies Corporation Stock Performance

as on September 17, 2025 at 9:42 pm IST

Day's Low
Day's High
$9.53
Day's Price Range
$9.77
$9.62
0.94%
Downside
1.56%
Upside
52 Week's Low
52 Week's High
$9.22
52-Week Price Range
$14.63
$9.62
4.16%
Downside
52.08%
Upside

Dynavax Technologies Corporation share price movements today

Previous Close: $9.70
Open: $9.74
Volume: 723.9K
Day's Low - High: $9.53 - $9.77
52 Week Low - High: $9.22 - $14.63

Dynavax Technologies Corporation Historical Returns

1 Month Return: -12.79 %
3 Month Return: -5.81 %
1 Year Return: -16.43 %
3 Year Return: -17.31 %
5 Year Return: 0 %

Dynavax Technologies Corporation Stock Fundamentals & Key Indicators

Check Dynavax Technologies Corporation market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.1B

EPS (TTM)

-0.5

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.76%

PE Ratio (TTM)

85.9

Industry PE ratio

-3.9281873111782475

P/B Ratio

PEG Ratio

EBITDA

12.9M

Revenue (TTM)

316.3M

Profit Margin

-16.67%

Return On Equity TTM

262079200.00%

Dynavax Technologies Corporation Stock Valuation

Track how Dynavax Technologies Corporation P/E has moved over time to understand its valuation trends.

Dynavax Technologies Corporation in the last 5 years

Overview
Trends

Lowest (5.90x)

December 31, 2022

Industry (-3.93x)

September 17, 2025

Today (85.90x)

September 17, 2025

Highest (104.30x)

June 30, 2024

LowHigh

Today’s Price to Earnings Ratio: 85.90x

Dynavax Technologies Corporation vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Dynavax Technologies Corporation with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Dynavax Technologies Corporation	BUY	$1.1B	NA	85.9	-16.67%
United Therapeutics Corporation	BUY	$18.0B	NA	15.52	40.36%
Haleon Plc Spon Ads	BUY	$44.0B	NA	21.51	13.81%
Neurocrine Biosciences Inc.	BUY	$14.0B	38.31%	41.69	13.88%
Zoetis Inc.	BUY	$65.4B	-8.86%	25.38	27.83%

Stock Returns calculator for Dynavax Technologies Corporation Stock including INR - Dollar returns

The Dynavax Technologies Corporation stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Dynavax Technologies Corporation investment value today

Current value as on today

₹90,033

Returns

₹9,967

(-9.97%)

Returns from Dynavax Technologies Corporation Stock

₹14,565 (-14.56%)

Dollar Returns*

₹4,598 (+4.6%)

Analyst Recommendation on Dynavax Technologies Corporation Stock

Based on 12 analysts

BUY

83.33%

Buy

16.67%

Hold

0.00%

Sell

Based on 12 analysts, 83.33% of analysts recommend a 'BUY' rating for Dynavax Technologies Corporation. Average target price of $22.8

Dynavax Technologies Corporation Share Price Target

Get share price movements and forecasts by analysts on Dynavax Technologies Corporation.

What analysts predicted

57.81%UPSIDE

Target Price

$22.8

Current Price

$9.62

Analyzed by

12 Analysts

Target

$22.80

Dynavax Technologies Corporation target price $22.8, a slight upside of 57.81% compared to current price of $9.62. According to 12 analysts rating.

Dynavax Technologies Corporation Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	46	60	69	55	50	73	80	72	68	95
Gross Profit	32	46	56	46	39	61	67	58	54	81
Operating Income	-17	-3	5	-8	-16	6	10	-1	-23	14
EBITDA	-20	7	17	4	-7	18	23	11	-94	24
Interest Expense	1	1	1	1	1	1	1	1	1	1
Depreciation	1	1	1	1	1	1	2	2	2	2
Income Before Tax	-23	4	14	0	-11	14	19	7	-97	21
Income Tax Expense	0	0	0	0	-2	3	2	0	-1	2
Net Income	-24	3	14	0	-8	11	17	7	-96	18
Net Profit Margin	-51.85%	5.69%	20.56%	0.39%	-17.17%	15.43%	21.82%	9.79%	-140.98%	19.62%

Dynavax Technologies Corporation Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	4	11	0	8	35	46	439	722	232	277
Gross Profit	4	11	0	-13	15	32	265	460	182	227
Operating Income	-105	-110	-96	-153	-121	-75	134	283	-37	-4
EBITDA	-104	-108	-90	-135	-114	-46	95	307	9	45
Interest Expense	0	0	-	9	16	19	11	6	6	6
Depreciation	-	-	4	14	21	9	7	6	6	8
Income Before Tax	-106	-112	-95	-158	-152	-75	77	294	-4	30
Income Tax Expense	0	-3	1	3	-1	16	0	1	2	3
Net Income	-106	-112	-95	-158	-152	-75	76	293	-6	27
Net Profit Margin	-2636.89%	-1018.24%	-29099.08%	-1938.27%	-433.29%	-161.63%	17.46%	40.56%	-2.75%	9.85%

Dynavax Technologies Corporation Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	3	14	0	-8	11	17	7	-96	18
Operating Cash Flow	28	31	13	-16	10	19	53	-19	23
Investing Cash Flow	24	-106	-20	2	-28	-15	23	6	94
Financing Cash Flow	0	2	1	-4	-1	2	-98	-31	-71
Change in Cash	52	-72	-4	-18	-19	6	-23	-44	47

Dynavax Technologies Corporation Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-112	-95	-158	-152	-75	76	293	-6	27
Operating Cash Flow	-107	-77	-131	-121	-92	335	62	100	66
Investing Cash Flow	86	-108	55	-42	-26	14	-315	-153	-18
Financing Cash Flow	0	187	99	154	109	55	19	1	-102
Change in Cash	-20	2	22	-9	-7	404	-234	-51	-54

Global Institutional Holdings in Dynavax Technologies Corporation

Funds	Holdings
BlackRock Inc	17.31%
Deep Track Capital, LP	15.18%
Vanguard Group Inc	7.42%
State Street Corp	5.79%
TANG CAPITAL MANAGEMENT LLC	4.9%

See all

Insights on Dynavax Technologies Corporation

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 68.16M → 95.44M (in $), with an average increase of 28.6% per quarter
POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -96.09M → 18.72M (in $), with an average increase of 613.3% per quarter
NO EFFECT
Against Peers
In the last 3 years, United Therapeutics Corporation has given 82.5% return, outperforming this stock by 97.3%
NO EFFECT
Against Peers
In the last 1 year, United Therapeutics Corporation has given 15.3% return, outperforming this stock by 29.2%
NEGATIVE IMPACT
Price Dip
In the last 1 month, DVAX stock has moved down by -10.1%

About Dynavax Technologies Corporation

dynavax technologies corporation is a clinical-stage biopharmaceutical company that develops products to prevent and treat infectious and inflammatory diseases and cancer. our clinical-stage product candidates include: phase 3 heplisav-b ™ adult hepatitis b vaccine phase 1/2 cancer immunotherapy phase 2 asthma therapy - partnered with astrazeneca in europe, dynavax manufactures hepatitis b surface antigen for heplisav-b.

Organisation	Dynavax Technologies Corporation
Headquarters	2100 Powell Street, EmeryVille, CA, United States, 94608
Industry	Health Technology
CEO	Mr. Ryan Spencer
E-voting on shares	Click here to vote

Key Management of Dynavax Technologies Corporation

Name	Title
Ms. Kelly MacDonald CPA	Senior VP & CFO
Mr. John L. Slebir	Senior VP & General Counsel
Mr. Donn Casale	Senior VP & Chief Commercial Officer
Dr. Dong Yu	Senior Vice President of Research
Mr. Ryan Spencer	CEO & Director
Mr. David F. Novack	President & COO
Mr. Jeff P. Coon	Senior VP & Chief Human Resources Officer
Mr. Paul Cox	VP of Investor Relations & Corporate Communications
Dr. Robert Janssen M.D.	Chief Medical Officer and Senior VP of Clinical Development, Medical & Regulatory Affairs
Mr. Joseph Metzinger	VP & Chief Accounting Officer

FAQs

What is Dynavax Technologies Corporation share price today?

Dynavax Technologies Corporation share price today is $9.62 as on September 17, 2025 at 9:42 pm IST. Dynavax Technologies Corporation share today touched a day high of $9.77 and a low of $9.53.

What is the 52 week high and 52 week low for Dynavax Technologies Corporation share?

Dynavax Technologies Corporation share touched a 52 week high of $14.63 on March 7, 2025 and a 52 week low of $9.22 on May 14, 2025. Dynavax Technologies Corporation stock price today i.e. September 17, 2025 at 9:42 pm IST is trending at $9.62,which is 34.24% down from its 52 week high and 4.34% up from its 52 week low.

What is Dynavax Technologies Corporation's market capitalisation today?

Dynavax Technologies Corporation market capitalisation is $0.00T as on September 17, 2025 at 9:42 pm IST.

How to invest in Dynavax Technologies Corporation Stock (DVAX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Dynavax Technologies Corporation on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Dynavax Technologies Corporation Shares that will get you 0.1559 shares as per Dynavax Technologies Corporation share price of $9.62 per share as on September 17, 2025 at 9:42 pm IST.

What is the minimum amount required to buy Dynavax Technologies Corporation Stock (DVAX) from India?

Indian investors can start investing in Dynavax Technologies Corporation (DVAX) shares with as little as ₹87.816 or $1 (as of September 17, 2025 at 9:42 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Dynavax Technologies Corporation stock (as per the Rupee-Dollar exchange rate as on September 17, 2025 at 9:42 pm IST). Based on Dynavax Technologies Corporation share’s latest price of $9.62 as on September 17, 2025 at 9:42 pm IST, you will get 1.0395 shares of Dynavax Technologies Corporation. Learn more about fractional shares .